New MIMS Learning Essentials resource focuses on the latest clinical guidance

New MIMS Learning Essentials resource focuses on the latest clinical guidance

A brand new resource called MIMS Learning Essentials...

RSS Feed

Latest news

'Innovative' heart failure treatment approved by NICE

'Innovative' heart failure treatment approved by NICE

A new type of drug to treat heart failure, which could...

New NICE guidance urges safer use of controlled drugs

New NICE guidance urges safer use of controlled drugs

NICE has published guidance to support the safe use...

Cardiac warning for Parkinson's medications

Cardiac warning for Parkinson's medications

Combined treatment with apomorphine and domperidone...

Necitumumab: new treatment for advanced squamous non-small cell lung cancer

Necitumumab: new treatment for advanced squamous non-small cell lung cancer

Portrazza (necitumumab) in combination with gemcitabine...

Avoid live vaccines in immunosuppressed patients, MHRA reminds clinicians

Avoid live vaccines in immunosuppressed patients, MHRA reminds clinicians

Healthcare professionals are warned to exclude the...


New and deleted products

Promo Image

New Products

Products added to MIMS

Promo Image

Deleted Products

Products removed from MIMS


Latest CPD from MIMS Learning


Most popular

Management of Type 2 Diabetes (NICE Guideline)

Summary of NICE guidance on treatment of type 2 diabetes.

Antidepressants, a Guide to Switching and Withdrawing

Instructions for changing or stopping antidepressants.

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Insulin Preparations

Types, presentations and profiles of insulin products.

Menopause: diagnosis and management (NICE Guideline)

Summary of NICE guidance on menopause.


Featured MIMS resources

Promo Image

Calcium and Vitamin D Supplements 


Formulations, doses and costs of osteoporosis supplements.
Promo Image

Management of Type 2 Diabetes


Summary of NICE guidance on treatment of type 2 diabetes.

Patient fact sheets

Browse the MIMS patient fact sheet library and find printable patient information on topics from acne to yellow fever.

Allergies

Hay Fever

Thyroid Disease


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Elocta (efmoroctocog alfa)

Feraccru (ferric maltol)

Fertavid (follitropin beta)

Fluomizin (dequalinium chloride)

Orkambi (lumacaftor/ivacaftor)

Zalviso (sufentanil)


Latest from MIMS Dermatology

1 CPD credit: Management of atopic eczema in children

Compliance is the key to effective therapy. By Dr Andre...

1 CPD credit: Urgent referrals in dermatology

An overview of conditions requiring urgent referral....

The importance of early diagnosis in Lyme disease

A thorough history and recognition of the erythema...


Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.

This site is intended for healthcare professionals.